Robert Park, MD
Otolaryngology · Edison, NJNPI 1710908595
Payments from drug & device makers
Across 69 payments — averaging $14.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- GSK$508
- Sanofi$364
- Ambu Inc.$30
- Amgen$18
- Intersect ENT, Inc.$16
- AstraZeneca$16
- plus $67 from 5 others
What the payments were for
- Food & beverage$1,019100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| GSK | 34 | $508 |
| Sanofi | 25 | $364 |
| Ambu Inc. | 1 | $30 |
| Amgen | 1 | $18 |
| Intersect ENT, Inc. | 1 | $16 |
| AstraZeneca | 1 | $16 |
| Merck | 1 | $14 |
| Optinose US, Inc. | 1 | $13 |
| Acelrx Pharmaceuticals, Inc. | 1 | $13 |
| Glenmark Therapeutics Inc. | 2 | $13 |
| Jazz Pharmaceuticals Inc. | 1 | $13 |
How this compares
$1,019 in reported general payments places this provider in the 40th percentile of 232 otolaryngology providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Fluticasone Propionate | 640 | $8,781 |
| Azelastine Hcl | 201 | $6,469 |
| Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort | 107 | $5,299 |
| CefuroximeCefuroxime Axetil | 296 | $3,962 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 35 | $3,564 |
| Ofloxacin | 118 | $2,564 |
| Neomycin-Polymyxin-HcNeomycin/Polymyxin B/Hydrocort | 32 | $1,635 |
| Clindamycin Hcl | 136 | $1,155 |
| Methylprednisolone | 119 | $828 |
| Omeprazole | 71 | $563 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 59 | $492 |
| Azithromycin | 149 | $490 |
| Moxifloxacin Hcl | 15 | $431 |
| Mometasone Furoate | 25 | $256 |
| Ciprofloxacin Hcl | 38 | $255 |
Paid to pharmacies, not to this prescriber.
Other otolaryngology in Edison
- Jason LeeEdison$5K
- Nishant ReddyEast Windsor$133K
- Justin McCormickNew Brunswick$109K
- Andrew BlitzerHackensack$40K
- Rakesh PatelParamus$26K
- Giant LinFlorham Park$25K
- Jeffrey AroestyMount Arlington$23K
- Samir ShahVoorhees$16K
- Brian BensonHackensack$14K
- Bryan HoEnglewood$13K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.